Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Rare Influenza A (H3N2) Variants with Reduced Sensitivity to Antiviral Drugs
  • Published Date:

    Mar 2010

  • Source:
    Emerg Infect Dis. 16(3):493-496.
Filetype[PDF-199.60 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 329.65 KB]
    Personal Author:
    Ramirez-Gonzalez, José Ernesto; Gonzalez-Duran, Elizabeth; Alcantara-Perez, Patricia; Wong-Arambula, Claudia; Olivera-Diaz, Hiram; Cortez-Ortiz, Iliana; Barrera-Badillo, Gisela; Nguyen, Ha; Gubareva, Larisa; Lopez-Martinez, Irma; Díaz-Quiñonez, Jose Alberto; Lezana-Fernández, Miguel Angel; Gatell-Ramírez, Hugo Lopez; Villalobos, Jose Angel Cordova; Hernández-Avila, Mauricio; Alpuche-Aranda, Celia;
    Published Date:
    Feb 2011
    Source:
    Emerg Infect Dis. 17(2):283-286.
    Description:
    During May 2009-April 2010, we analyzed 692 samples of pandemic (H1N1) 2009 virus from patients in Mexico. We detected the H275Y substitution of the neuraminidase gene in a specimen from an infant with pandemic (H1N1) 2009 who was treated with oselta...
    File Type:
    Filetype[PDF - 329.65 KB]
  2. Filetype[PDF - 263.57 KB]
    Personal Author:
    McKimm-Breschkin, Jennifer L.; Selleck, Paul W.; Usman, Tri Bhakti; Johnson, Michael A.;
    Published Date:
    Sep 2007
    Source:
    Emerg Infect Dis. 13(9):1354-1357.
    Description:
    We tested the neuraminidase drug sensitivity of clade 1 and clade 2 influenza A (H5N1). All viruses demonstrated similar sensitivity to zanamivir, but compared with the 2004 clade 1 viruses, the Cambodian 2005 viruses were 6-fold less sensitive and t...
    File Type:
    Filetype[PDF - 263.57 KB]
  3. Filetype[PDF - 3.75 MB]
    Personal Author:
    Schuchat, Anne; Jernigan, Daniel B.; Wentworth, David E.; Fry, Alicia M.; Iskander, John K.; Thorpe, Phoebe; Laird, Susan;
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication.. National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division..
    Published Date:
    January 16, 2018
    Series:
    Public Health grand rounds ; 2018 January 16
    Description:
    January 16, 2018 at 1:00 p.m. (ET)Note: January 16 CDC Public Health Grand Rounds topic change to: “Public Health Response to Severe Influenza”The topic for CDC’s Public Health Grand Rounds on January 16 will now focus on influenza. With the sp...
    File Type:
    Filetype[PDF - 3.75 MB]
  4. Filetype[PDF - 368.76 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    December 4, 2014
    Series:
    CDC Influenza Division key points
    Influenza (flu)
    Description:
    CDC_Influenza_Division_Key_Points.pdf
    File Type:
    Filetype[PDF - 368.76 KB]
  5. Filetype[PDF - 310.86 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    December 3, 2014
    Series:
    HAN ; 374
    Description:
    December 03, 2014, 16:00 ET (4:00 PM ET)CDCHAN-00374CDC is reminding clinicians of the benefits of influenza antiviral medications and urging continued influenza vaccination of unvaccinated patients this influenza season.Summary: Influenza activity i...
    File Type:
    Filetype[PDF - 310.86 KB]